Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carcinogenesis
- 10 April 2008
- journal article
- carcinogenesis
- Published by Wiley in International Journal of Cancer
- Vol. 123 (2) , 296-302
Abstract
Epigenetic aberration is known to be important in human carcinogenesis. Promoter methylation status of RAS effector related genes, RASSF1A, RASSF2A, hDAB2IP (m2a and m2b regions) and BLU, was evaluated in 76 endometrial carcinomas and their non‐neoplastic endometrial tissue by methylation specific PCR. Hypermethylation of at least one of the 5 genes was detected in 73.7% of carcinomas. There were significant correlations between methylation of hDAB2IP and RASSF1A, RASSF2A (p = 0.042, p = 0.012, respectively). Significantly, more frequent RASSF1A hypermethylation was found in Type I endometrioid carcinomas than Type II carcinomas (p = 0.049). Among endometrioid cancers, significant association between RASSF1A hypermethylation and advanced stage, as well as between methylation of hDAB2IP at m2a region with deep myometrial invasion (p < 0.05) was observed. mRNA expression of RASSF1A, RASSF2A and BLU in endometrial cancer cell lines significantly increased after treatment with the demethylating agent 5‐Aza‐2′‐deoxycytidine supporting the repressive effect of hypermethylation on their transcription. Immunohistochemical study of DNMT1 on eight normal endometrium, 16 hyperplastic endometrium without atypia, 40 atypical complex hyperplasia and 79 endometrial carcinomas showed progressive increase in DNMT1 immunoreactivity from normal endometrium to endometrial hyperplasia and endometrioid carcinomas (p = 0.001). Among carcinomas, distinctly higher DNMT1 expression was observed in Type I endometrioid carcinomas (p < 0.001). DNMT1 immunoreactivity correlated with RASSF1A and RASSF2A methylation (p < 0.05). The data suggested that hypermethylation of RAS related genes, particularly RASSF1A, was involved in endometrial carcinogenesis with possible divergent patterns in different histological types. DNMT1 protein overexpression might contribute to such aberrant DNA hypermethylation of specific tumor suppressor genes in endometrial cancers.Keywords
Funding Information
- University of Hong Kong Conference and Research Committee
This publication has 47 references indexed in Scilit:
- The Ras-association domain family (RASSF) members and their role in human tumourigenesisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2007
- RASSF1A hypermethylation and its inverse correlation with BRAF and/or KRAS mutations in MSI‐associated endometrial carcinomaInternational Journal of Cancer, 2006
- DNA methylation of multiple tumor-related genes in association with overexpression of DNA methyltransferase 1 (DNMT1) during multistage carcinogenesis of the pancreasCarcinogenesis, 2006
- Epigenetic and genetic alterations of p33 ING1b in ovarian cancerCarcinogenesis, 2005
- Hypermethylation of RASSF1A and BLU tumor suppressor genes in non‐small cell lung cancer: Implications for tobacco smoking during adolescenceInternational Journal of Cancer, 2004
- Aberrant promoter methylation of human DAB2 interactive protein (hDAB2IP) gene in lung cancersInternational Journal of Cancer, 2004
- RASSF2 Is a Novel K-Ras-specific Effector and Potential Tumor SuppressorJournal of Biological Chemistry, 2003
- Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinomaOncogene, 2003
- Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancersOncogene, 2003
- DNMT1 and DNMT3b cooperate to silence genes in human cancer cellsNature, 2002